Need professional-grade analysis? Visit stockanalysis.com
$43.32M
N/A
N/A
N/A
Telomir Pharmaceuticals, Inc. Common Stock (TELO) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.37, down 1.44% from the previous close.
Over the past year, TELO has traded between a low of $1.08 and a high of $2.75. The stock has lost 46.5% over this period. It is currently 50.2% below its 52-week high.
Telomir Pharmaceuticals, Inc. Common Stock has a market capitalization of $43.32M.
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Side-by-side comparison against top Healthcare peers.